UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: A pooled analysis of topotecan second-line trials

European journal of cancer (1990), 2014-09, Vol.50 (13), p.2211-2218

2014

Volltextzugriff (PDF)

Comparison Between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-small Cell Lung Cancer (NSCLC) and in Fine-Needle Aspirates from Distant Metastatic Sites

Journal of thoracic oncology, 2008-01, Vol.3 (1), p.18-22

2008

Volltextzugriff (PDF)

Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it?

Surgery today (Tokyo, Japan), 2011-02, Vol.41 (2), p.222-229

2011

Volltextzugriff (PDF)

Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma

Tumori, 2007-03, Vol.93 (2), p.138-144

2007

Volltextzugriff (PDF)

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

JNCI : Journal of the National Cancer Institute, 2023-01, Vol.115 (1), p.29-42

2023

Volltextzugriff (PDF)

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2016-11, Vol.375 (19), p.1823-1833

2016

Volltextzugriff (PDF)

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

American journal of clinical dermatology, 2022-03, Vol.23 (2), p.247-255

2022

Volltextzugriff (PDF)

Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials

European urology focus, 2022-03, Vol.8 (2), p.514-521

2022

Volltextzugriff (PDF)

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2019-12, Vol.20 (12), p.1655-1669

2019

Volltextzugriff (PDF)

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

Anti-cancer drugs, 2024-01, Vol.35 (1), p.86

2024

Volltextzugriff (PDF)

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

Journal of clinical oncology, 2002-10, Vol.20 (19), p.3947-3955

2002

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.143-150

2003

Volltextzugriff (PDF)

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1281-1287

2017

Volltextzugriff (PDF)

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

Anticancer research, 2008-01, Vol.28 (1B), p.507-513

2008

Volltextzugriff (PDF)

Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study

Applied immunohistochemistry & molecular morphology, 2018-08, Vol.26 (7), p.489-494

2018

Volltextzugriff (PDF)

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

Diseases of the colon & rectum, 2020-12, Vol.63 (12), p.1602-1609

2020

Volltextzugriff (PDF)

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Clinical lung cancer, 2021-09, Vol.22 (5), p.423-431

2021

Volltextzugriff (PDF)

Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience

Lung cancer (Amsterdam, Netherlands), 2022-12, Vol.174, p.91-96

2022

Volltextzugriff (PDF)

Multifactorial Central Nervous System Recurrence Susceptibility in Patients With HER2-Positive Breast Cancer: Epidemiological and Clinical Data From a Population-Based Cancer Registry Study

Cancer, 2011-05, Vol.117 (9), p.1837-1846

2011

Volltextzugriff (PDF)

The pathogenic and colonization potential of Candida africana

Microbes and infection, 2024-01, Vol.26 (1-2), p.105230, Article 105230

2024

Volltextzugriff (PDF)

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1283-1289

2019

Volltextzugriff (PDF)

Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan

Lung cancer (Amsterdam, Netherlands), 2014-10, Vol.86 (1), p.91-95

2014

Volltextzugriff (PDF)

Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy

Cancer Immunology, Immunotherapy : CII, 2024-10, Vol.73 (12), p.246, Article 246

2024

Volltextzugriff (PDF)

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS‐P WT GIST

Genes chromosomes & cancer, 2019-09, Vol.58 (9), p.636-642

2019

Volltextzugriff (PDF)

26 – 50 von 138

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(138)

Sprache

Englisch
(138)

Erscheinungsjahr

n.n

Thema

Humans
(138)
Science & Technology
(128)
Life Sciences & Biomedicine
(125)
Middle Aged
(103)
Oncology
(103)
Male
(102)
Aged
(99)
Adult
(72)
Lung Neoplasms - Drug Therapy
(59)
Lung Neoplasms - Pathology
(51)
Aged, 80 And Over
(48)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(45)
Treatment Outcome
(41)
Biological And Medical Sciences
(37)
Medical Sciences
(36)
Carcinoma, Non-Small-Cell Lung - Pathology
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Neoplasm Staging
(30)
Chemotherapy
(28)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(19)
Tumori
(13)
Journal Of Clinical Oncology
(9)
Cancer
(7)
American Journal Of Clinical Oncology
(6)
Anticancer Research
(5)
Journal Of Thoracic Oncology
(5)
Clinical Lung Cancer
(4)
The New England Journal Of Medicine
(4)
Plos One
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: A pooled analysis of topotecan second-line trials

Comparison Between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-small Cell Lung Cancer (NSCLC) and in Fine-Needle Aspirates from Distant Metastatic Sites

Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it?

Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience

Multifactorial Central Nervous System Recurrence Susceptibility in Patients With HER2-Positive Breast Cancer: Epidemiological and Clinical Data From a Population-Based Cancer Registry Study

The pathogenic and colonization potential of Candida africana

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan

Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS‐P WT GIST

Aktive Filter

Suchergebnisse filtern